Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Total Non-Current Liabilities: 2009-2025

Historic Total Non-Current Liabilities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $34.1 million.

  • Cumberland Pharmaceuticals' Total Non-Current Liabilities fell 26.07% to $34.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year decrease of 26.07%. This contributed to the annual value of $46.7 million for FY2024, which is 1.47% up from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Total Non-Current Liabilities stood at $34.1 million, which was up 0.65% from $33.9 million recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Total Non-Current Liabilities ranged from a high of $49.4 million in Q4 2022 and a low of $33.2 million during Q2 2021.
  • For the 3-year period, Cumberland Pharmaceuticals' Total Non-Current Liabilities averaged around $43.1 million, with its median value being $45.9 million (2024).
  • In the last 5 years, Cumberland Pharmaceuticals' Total Non-Current Liabilities spiked by 43.64% in 2022 and then decreased by 26.16% in 2025.
  • Cumberland Pharmaceuticals' Total Non-Current Liabilities (Quarterly) stood at $34.4 million in 2021, then surged by 43.64% to $49.4 million in 2022, then declined by 6.69% to $46.1 million in 2023, then rose by 1.47% to $46.7 million in 2024, then fell by 26.07% to $34.1 million in 2025.
  • Its Total Non-Current Liabilities was $34.1 million in Q3 2025, compared to $33.9 million in Q2 2025 and $35.6 million in Q1 2025.